Stevanato Group S.p.A. (NYSE:STVN) Shares Purchased by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. raised its stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 14.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 186,447 shares of the company's stock after acquiring an additional 23,230 shares during the quarter. Balyasny Asset Management L.P. owned approximately 0.06% of Stevanato Group worth $4,063,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in STVN. TimesSquare Capital Management LLC boosted its stake in Stevanato Group by 114.6% during the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company's stock valued at $71,657,000 after acquiring an additional 1,756,100 shares during the last quarter. Jennison Associates LLC bought a new position in Stevanato Group during the 4th quarter valued at $20,239,000. Mutual of America Capital Management LLC bought a new position in Stevanato Group during the 4th quarter valued at $13,848,000. Ranger Investment Management L.P. bought a new position in Stevanato Group during the 4th quarter valued at $12,940,000. Finally, Artisan Partners Limited Partnership lifted its position in shares of Stevanato Group by 28.7% in the 4th quarter. Artisan Partners Limited Partnership now owns 2,355,799 shares of the company's stock worth $51,333,000 after buying an additional 524,989 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on STVN. UBS Group reduced their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday, March 7th. William Blair restated an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. Finally, Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of €25.70 ($28.88).

Stevanato Group Stock Performance

Shares of STVN stock traded up €0.76 ($0.85) during trading hours on Tuesday, reaching €24.42 ($27.44). The stock had a trading volume of 374,000 shares, compared to its average volume of 350,972. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group S.p.A. has a twelve month low of €16.56 ($18.61) and a twelve month high of €24.90 ($27.98). The firm has a 50-day simple moving average of €21.30 and a 200-day simple moving average of €21.08. The firm has a market capitalization of $7.40 billion, a PE ratio of 51.96, a price-to-earnings-growth ratio of 7.18 and a beta of 0.51.

Stevanato Group (NYSE:STVN - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, hitting analysts' consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €352.68 million for the quarter, compared to analysts' expectations of €346.26 million. As a group, equities analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Stevanato Group Increases Dividend

The company also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Investors of record on Thursday, June 5th will be issued a $0.0613 dividend. This represents a dividend yield of 0.3%. The ex-dividend date is Thursday, June 5th. This is a boost from Stevanato Group's previous annual dividend of $0.05. Stevanato Group's dividend payout ratio (DPR) is 11.76%.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.